Skip to content

ASCELIA

AN ONCOLOGY-DEDICATED DRUG DEVELOPMENT COMPANY

 
  • En
  • Sv
  • About us
    • Management
    • Board of Directors
  • Therapeutic areas
    • Liver metastases
    • Gastric Cancer
  • Pipeline
    • Orviglance®
    • Oncoral
  • Partnering
  • Investors
    • Press releases
    • Financial reports
    • Presentations & articles
    • Events
    • Share information
    • Shareholders
    • Insiders
    • Equity research
    • Financial calendar
  • Governance
    • General Meeting
    • Articles of Association
    • Nomination Committee
    • Board of Directors
    • Audit Committee
    • Remuneration Committee
    • Commercialization Committee
    • Remuneration
    • Auditors
    • Internal control
  • Career
    • Open positions
    • Our values
  • Contact
18 events found.

Events

Events Search and Views Navigation

Event Views Navigation

  • List
Today
  • September 2021

  • Tue 7

    LSX Nordic Congress – 4th Annual Congress (Virtual)

    2021-09-07 @ 16:00 - 17:00

    Magnus Corfitzen, CEO at Ascelia Pharma  will attend the LSX Nordic Congress, he will also participate in the panel discussion: Preparing for and Executing Successful Cross-Border Transations   

  • Tue 7

    LSX Nordic Congress – 4th Annual Congress (Virtual)

    2021-09-07 @ 16:00 - 17:00

    Magnus Corfitzen, CEO at Ascelia Pharma  will attend the LSX Nordic Congress, he will also participate in the panel discussion: Preparing for and Executing Successful Cross-Border Transations   

  • Mon 27

    Magnus Corfitzen CEO at Ascelia Pharma will present at HC Andersen Capital

    2021-09-27 @ 12:30 - 13:00

    Magnus Corfitzen will present Oncoral and the collaboration agreement with Taiho Oncology Inc. https://hcandersencapital.dk/event/ascelia-pharma-oncoral-samarbejde-med-det-amerikansk-baserede-taiho-oncology/  

  • Tue 28

    Chief Medical Officer Carl Bjartmar will present Ascelia Pharma at Aktiespararna in Lund

    2021-09-28 @ 11:00 - 11:30
    Elite Hotel Ideon, Scheelevägen 27

    For more information: Aktiedagen Lund 28 september | Aktiespararna Take the opportunity to ask your questions  by sending a text message to 079-347 98 45 or emailing event@aktiespararna.se. Your questions […]

  • Thu 30

    Magnus Corfitzen CEO at Ascelia Pharma will present at Erik Penser Bank Orphan Drugs’s Day

    2021-09-30 @ 10:05 - 10:45

    Magnus Corfitzen will present at the Erik Penser Bank  Orphan Drugs Day. To see the presentation live:  https://www.youtube.com/watch?v=pTc-DmaTlcA

  • October 2021

  • Tue 5

    Danske Bank Event Series: Life Science, Launch Phase

    2021-10-05 @ 11:00 - 11:45

    Ascelia Pharma's CEO Magnus Corfitzen will present at Danske Bank Life Science Event Series.

  • Wed 6

    Magnus Corfitzen CEO at Ascelia Pharma will present at Small & Mid Cap Seminar with Nordea Market & HC Andersen

    2021-10-06 @ 11:00 - 11:15

    Magnus Corfizen will give a company presentation. To register to the event: https://hcandersencapital643.clickmeeting.com/small-mid-cap-seminar-6-oktober-nordea-market-hc-andersen-capital/register

  • Thu 28

    Redeye Investor Forum Malmö

    2021-10-28 @ 19:00 - 19:20

    Magnus Corfitzen, CEO will give a company presentation at the Redeye Investor Forum - Malmö. To register: https://www.redeye.se/events/815883/investor-forum-6

  • November 2021

  • Thu 4

    Interim report 9M (January-September 2021)

    2021-11-04 @ 08:00

    Report will be released at 8.00am CET and conference call at 10.00am CET

  • Thu 11

    Redeye Life Science Day

    2021-11-11

    Magnus Corfitzen will give a company presentation at the Red Life Science Day. (time tbc) To register: https://www.redeye.se/events/815899/redeye-life-science-day-2021

  • December 2021

  • Wed 1

    RSNA – 28 November to 2 December 2021

    2021-12-01 @ 09:30 - 10:30
    Shortcut

    Dr. Kohkan Shamsi will present the abstract for Orviglance comparison study to gadolinium at the Annual Meeting of the Radiological Society of North America (RSNA).

  • Thu 2

    Danske Bank’s Winter Seminar 2 December 2021

    2021-12-02 @ 10:45 - 11:25
    IDA Conference Center

    Ascelia Pharma’s CEO Magnus Corfitzen will present at Danske Bank's Winter Seminar.  

  • January 2022

  • Wed 5

    11th Annual LifeSci Partners Corporate Access Event – 5 to 7 January 2022

    2022-01-05

    Ascelia Pharma will present at the 11th Annual LifeSci Partners Corporate Access Event, to register: https://www.meetmax.com/sched/event_78427/invitee_login.html

  • Fri 7

    The Best of Both Worlds: Defining Yourself When You Fit Into More Than One Basket

    2022-01-07 @ 16:00 - 17:00

    Magnus Corfitzen will participate in a panel discussion  where you can learn how successful biotech companies navigate advancing two unrelated pipeline assets and the key considerations encountered by management teams. […]

  • Thu 20

    Fight Cancer Seminar – Outlook 2022

    2022-01-20 @ 10:50 - 11:10

    Ascelia Pharma will present at the Fight Cancer Seminar, to register: https://www.redeye.se/events/825146/redeye-theme-fight-cancer-seminar-outlook-2022

  • Mon 31

    Aktiedagen in Lund

    2022-01-31 @ 18:30 - 19:00
    Elite Hotel Ideon, Scheelevägen 27

    Julie Waras Brogren, Chief Commercial Officer will present Ascelia Pharma in Lund/Online. To register: https://www.aktiespararna.se/aktiviteter/aktiedagen-lund-tema-life-science

  • February 2022

  • Thu 10

    Full year report 2021 (January-December 2021)

    2022-02-10 @ 08:00

    Report will be released at 8.00am CET and conference call at 10.00am CET

  • Thu 24

    Life Science Day with Erik Penser Bank

    2022-02-24 @ 09:55 - 10:25

    Julie Waras Brogren, Chief Commercial Officer will present Ascelia Pharma. Live presentation: Erik Penser Bank HealthCare-dag - Sal 1 - 24 februari 2022 - YouTube

  • Previous Events
  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
Learn more

About us

Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. […]
Learn more

Contact

Magnus Corfitzen will present at Redeye Orphan Drug Event with  Q&A panel discussions with  Redeye analysts. Live broadcast: https://www.redeye.se/events/870532/redeye-theme-orphan-drugs-2
Learn more

Our values

Our values inspire our ambitions, decision making and collaboration to help us reach our highest potential. INTEGRITY We build powerful relationship with mutual respect and adhere to the high ethical […]
  1. Start (en)
  2. Calendar
  3. List

About us

  • Start (en)
  • About us
  • Career
  • Contact
  • Privacy policy
  • About cookies
  • Cookie settings
  • IMPORTANT INFORMATION

Pipeline

  • Oncoral
  • Orviglance®

IR & Media

  • Subscribe to press releases
  • Press releases & News
  • Financial Reports

Contact us

Ascelia Pharma AB
Hyllie Boulevard 34
215 32 Malmö
Sweden
Phone: +46 735 17 91 18

info@ascelia.com

Follow us

 

Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. The company has two drug candidates – Orviglance® (former working name Mangoral) and Oncoral – in clinical development.

Ascelia Pharma has global headquarters in Malmö, Sweden, and is listed on Nasdaq Stockholm (ticker: ACE).

© Copyright 2021 - Ascelia Pharma AB | We use cookies to improve our services | Disclaimer Market data could be delayed. Delivered by Modular Finance.

Video
Cookies
We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings". Read our cookie policy
Settings Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy
  • Necessary
    These cookies are not optional. They are needed for the website to function.
  • Statistics
    In order for us to improve the website's functionality and structure, based on how the website is used.
  • Experience
    In order for our website to perform as well as possible during your visit. If you refuse these cookies, some functionality will disappear from the website.
  • Marketing
    By sharing your interests and behavior as you visit our site, you increase the chance of seeing personalized content and offers.
Save Accept all